Meanwhile, previous studies have shown that CD41+ patients with MDS are often therapy-resistant and show poor prognosis, and that CD41+ is often associated with complex and monosomal karyotypes [7–9]; the results of this study are in agreement with these findings. Here, ITGA2B is linked to myelodysplastic syndrome.